This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-12/IL-23 inhibitor.

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with IL-10 or an IL-10 agonist.

This invention relates to an ingestible drug delivery device configured for wireless communication with other ingestible drug delivery devices.

An ingestible apparatus for collecting samples from a target area of a gastrointestinal (GI) tract of a subject and/or for delivering a health-related substance thereto. An example ingestible apparatus includes a housing defining a sample compartment, a stopper configured to seal an access port, and an actuation assembly connected to the stopper. The actuation assembly is movable between a first working position where the access port is open and a second working position where the access port is sealed with the stopper. The apparatus also includes a dissolvable block configured to prevent the actuation assembly from moving between the first and second working positions until the apparatus is within a target area of the GI tract. The actuation assembly is configured, in the second working position, to apply a linear force at an interface between the stopper and a sealing surface to seal the access port with the stopper.

A device includes a capsule sized to pass through a lumen of a gastrointestinal tract; an enteric coating surround at least a portion of the capsule and configured to protect the capsule form stomach acid while allowing degradation of the capsule in the small intestine of the gastrointestinal tract; a plurality of functionalized particles disposed within the capsule, a plurality of tissue penetrating members configured to puncture a wall of the lumen of the intestinal tract; and an actuator having a first configuration and a second configuration. The actuator is configured to retain the plurality of functionalized particles within the capsule in the first configuration. The actuator is further configured to advance the plurality of functionalized particles from the capsule into a wall of the lumen of the gastrointestinal tract via the plurality of tissue penetrating members by the actuator transitioning from the first configuration to the second configuration.

The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.

Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the power sources of the invention.

Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the power sources of the invention.

A medical patch configured for being applied to a patient and for communicating with an in-vivo device located within the patient’s body; The medical patch comprises an adhesive surface configured for adhering the patch to the patient’s skin; and a communication arrangement configured for providing communication between the medical patch and the in-vivo device.

Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the power sources of the invention.